Tiger BioSciences Reports Interim Trial Data Showing Higher Diabetic Ulcer Closure Rates
CONSHOHOCKEN, PA — Tiger BioSciences reported interim results from a randomized controlled clinical trial showing that patients with non-healing diabetic foot ulcers treated with its caregraFT™ placental membrane allograft alongside …
Tiger BioSciences Reports Interim Trial Data Showing Higher Diabetic Ulcer Closure Rates Read More